DNA methylation Dependent Restriction of Tyrosine Hydroxylase Contributes to Pancreatic β-cell Heterogeneity

Abstract

<p>The molecular and functional heterogeneity of pancreatic b-cells is well recognized, but the underlying mechanisms remain unclear. Pancreatic islets harbor a subset of b-cells that co-express Tyrosine Hydroxylase (TH), an enzyme involved in synthesis of catecholamines that repress insulin secretion. Restriction of the TH+ b-cells within islets is essential for appropriate function in mice, such that higher proportion of these cells corresponds to reduced insulin secretion. Here, we use these cells as a model to dissect the developmental control of b-cell heterogeneity. We define the specific molecular and metabolic characteristics of TH+ b-cells, and show differences in their developmental restriction in mice and humans. We show that TH expression in b-cells is restricted by DNA methylation during b-cell differentiation. Ablation of <em>de novo</em> DNA methyltransferase Dnmt3a in the embryonic progenitors results in a dramatic increase in the proportion of TH+ b-cells, while b-cell specific ablation of Dnmt3a does not. We demonstrate that maintenance of <em>Th</em> promoter methylation is essential for its continued restriction in postnatal b-cells. Loss of <em>Th</em> promoter methylation in response to chronic overnutrition increases the number of TH+ b-cells, corresponding to impaired b-cell function. These results reveal a regulatory role of DNA methylation in determining b-cell heterogeneity.</p>